Shifali Dumeer, MD

Dr. Mark Francescone is board certified in diagnostic radiology with subspecialty training in both breast and body imaging. Dr. Francescone is an assistant professor of radiology at Columbia University Irving Medical Center and an assistant attending radiologist at NewYork-Presbyterian Hospital. Dr. Francescone is a member of the Radiological Society of North America, American Roentgen Ray Society and New York Roentgen Society.

Dr. Mikhail Doubrovin is an associate professor of radiology at the Columbia University Vagelos College of Physicians and Surgeons and an attending radiologist at NewYork-Presbyterian Hospital. He serves as interim chief of the Division of Nuclear Medicine. With background both in clinical and basic science molecular imaging and therapy, Dr. Doubrovin is experienced in all aspects of nuclear nedicine applications. Most of his clinical and research interest is focused on use of radiopharmaceuticals in diagnosis and treatment of cancer. He is also involved in development of and monitoring of immune cell therapy for cancer and allied diseases. During his previous practice at MSKCC and St. Jude Children's Research Hospital, Dr. Doubrovin paid special attention to treatment of children and young adults. Dr. Doubrovin is member of the Society of Nuclear Medicine and Molecular Imaging and the World Molecular Imaging Society.

Akiva Mintz, MD, PhD, is a physician-scientist whose translational research focuses on developing and personalizing cancer therapies using non-invasive molecular imaging. He obtained his medical and graduate degrees at the Pennsylvania State University College of Medicine where he helped discover and therapeutically exploit a new cancer restricted biomarker in malignant brain cancer. Dr. Mintz subsequently completed a Nuclear Medicine Residency and an NIH-sponsored molecular imaging fellowship at the University of Pennsylvania, where he developed novel preclinical multimodality imaging tools to non-invasively visualize disease and early response to therapy. Dr. Mintz is dual-board certified in Nuclear Medicine and Clinical Informatics. In addition to his medical training, Dr. Mintz is a CFA charterholder and completed a Masters in Healthcare Administration (MHA) at the University of North Carolina at Chapel Hill. Dr. Mintz is a professor of radiology at Columbia University Irving Medical Center and an attending radiologist at NewYork-Presbyterian Hospital. He serves as vice chair of translational research for the Department of Radiology and is director of the Columbia University PET Center and division chief of the Division of Nuclear Medicine. Prior to Columbia, Dr. Mintz worked at Wake Forest, where he held a number of leadership roles, including vice chair of radiology and section head of nuclear medicine. Dr. Mintz was also the associate director of the Wake Forest Clinical and Translational Science Institute and co-leader of the Cancer Biology and Biochemistry Program of the NCI-designated Wake Forest Comprehensive Cancer Center. Dr. Mintz’s cross-translational research efforts exploit nuclear-based molecular imaging and therapy techniques to personalize anti-cancer therapies. His work is funded by multiple NIH grants and the American Cancer Society.